XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Stock Options Issued and Outstanding Activities (Details) - $ / shares
6 Months Ended 9 Months Ended
Jun. 30, 2021
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]    
Number of Stock Options, Outstanding Balance Beginning 1,399,243 1,399,243
Weighted Average Exercise Price, Outstanding Balance Beginning $ 0.61 $ 0.61
Remaining Contractual Term (Years), Beginning Outstanding   8 years
Number of Stock Options, Granted [1]  
Weighted Average Exercise Price, Granted [1]  
Number of Stock Options, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Stock Options, Forfeited  
Weighted Average Exercise Price, Forfeited  
Number of Stock Options, Outstanding Balance Ending   1,399,243
Weighted Average Exercise Price, Outstanding Balance Ending   $ 0.61
Remaining Contractual Term (Years), Ending Outstanding   7 years 6 months
Number of Stock Options Vested and Exercisable   1,120,526
Weighted Average Exercise Price, Vested and Exercisable $ 0.57  
Remaining Contractual Term (Years), Vested and Exercisable 7 years 4 months 24 days  
[1] Stock options granted under the Lucid Diagnostics Inc. 2018 Equity Plan generally vest ratably over twelve quarters, with the vesting commencing with the grant date quarter, and have a ten-year contractual term from date-of-grant.